Virtu Financial LLC - CHINA SXT PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

CHINA SXT PHARMACEUTICALS IN's ticker is and the CUSIP is G2161P132. A total of 6 filers reported holding CHINA SXT PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
Virtu Financial LLC ownership history of CHINA SXT PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2023$11
-77.1%
39,427
-55.8%
0.00%
-83.3%
Q4 2022$48
-99.8%
89,157
+499.7%
0.01%
+200.0%
Q2 2022$26,000–14,868–0.00%–
 Download
Other shareholders
CHINA SXT PHARMACEUTICALS IN shareholders Q4 2022
NameSharesValueWeighting ↓
Baader Bank Aktiengesellschaft 12,916$1,4150.00%
UBS Group AG 29,870$3,6740.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
ACADIAN ASSET MANAGEMENT LLC 105,039$120.00%
Citadel Advisors 191,339$23,5350.00%
TWO SIGMA SECURITIES, LLC 49,965$6,1460.00%
HRT FINANCIAL LP 48,507$50.00%
LEVEL FOUR ADVISORY SERVICES, LLC 42,771$5,2610.00%
Qube Research & Technologies Ltd 50$60.00%
View complete list of CHINA SXT PHARMACEUTICALS IN shareholders